KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

AbCellera Biologics (ABCL) Other Gross PP&E Adjustments (2020 - 2025)

Historic Other Gross PP&E Adjustments for AbCellera Biologics (ABCL) over the last 6 years, with Q3 2025 value amounting to $223.4 million.

  • AbCellera Biologics' Other Gross PP&E Adjustments rose 704.92% to $223.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.4 million, marking a year-over-year increase of 704.92%. This contributed to the annual value of $210.3 million for FY2024, which is 3641.28% up from last year.
  • AbCellera Biologics' Other Gross PP&E Adjustments amounted to $223.4 million in Q3 2025, which was up 704.92% from $219.6 million recorded in Q2 2025.
  • In the past 5 years, AbCellera Biologics' Other Gross PP&E Adjustments registered a high of $233.8 million during Q2 2024, and its lowest value of $31.0 million during Q1 2021.
  • Over the past 5 years, AbCellera Biologics' median Other Gross PP&E Adjustments value was $208.7 million (recorded in 2024), while the average stood at $172.7 million.
  • Per our database at Business Quant, AbCellera Biologics' Other Gross PP&E Adjustments surged by 33235.36% in 2021 and then tumbled by 756.65% in 2025.
  • AbCellera Biologics' Other Gross PP&E Adjustments (Quarter) stood at $101.6 million in 2021, then soared by 52.39% to $154.9 million in 2022, then fell by 0.47% to $154.2 million in 2023, then skyrocketed by 36.41% to $210.3 million in 2024, then grew by 6.22% to $223.4 million in 2025.
  • Its last three reported values are $223.4 million in Q3 2025, $219.6 million for Q2 2025, and $213.7 million during Q1 2025.